Is TB-500 Legal in Illinois? How to Access It Legally
HealthRX.com
No established federal route to TB-500 exists today
See the public record for TB-500
At a glance
- What it is / A 7-amino-acid fragment of thymosin beta-4 [1]
- FDA approval / None [1]
- FDA compounding lists / On no category of either list [2][3][4]
- Advisory committee / Voted July 23, 2026 to recommend adding it; advice only [7]
- HHS draft policy / Filed October 28, 2026; not binding, not a listing [5]
- Sport / Prohibited at all times by WADA [8]
What TB-500 is
TB-500 is a synthetic 7-amino-acid fragment of thymosin beta-4 — residues 17 to 23, N-acetylated, about 889 g/mol — not the full 43-amino-acid protein [1]. FDA found several salts and derivatives, including different active moieties, sold under the same name [1]. It is sold online as "research use only" powder, and FDA found no pharmacy marketing a compounded TB-500 product and no outsourcing facility reporting one [1].
The federal position on compounding
A state-licensed pharmacy may compound with a bulk substance only if it meets a USP or National Formulary monograph, is a component of an FDA-approved drug, or appears on FDA's bulks list [4]. FDA's July 2026 review found no USP or National Formulary monograph and no FDA-approved drug containing TB-500 [1]. TB-500 appears in none of the categories on FDA's list for state-licensed pharmacies and physicians (updated May 14, 2026) or on the outsourcing facility list (updated March 21, 2025), and FDA's category 1 policy does not cover it [2][3][4]. It sits in the "nominated but withdrawn" table on FDA's page about substances that may raise significant safety risks; removal from that category was not a finding that it is safe [9]. Compounded drugs are not FDA-approved, and FDA does not review their safety, effectiveness or quality before marketing [5].
The July 2026 recommendation and the draft HHS policy
FDA staff proposed in July 2026 that neither TB-500 free base nor TB-500 acetate be added to the bulks list, citing inconsistent naming, no impurity or aggregate data, no evidence of effectiveness for wound healing and no human data [1]. The Pharmacy Compounding Advisory Committee voted in favor of adding it on July 23, 2026, against the staff recommendation; its advice is not binding [7]. TB-500 is not on the bulks list, and adding it takes formal rulemaking [5][7].
HHS filed a draft enforcement-discretion policy on October 28, 2026 (Federal Register document 2026-22192; publication scheduled October 30, 2026, with comments due two weeks after publication), naming TB-500 among six peptides [5][6]. It covers TB-500 acetate given by subcutaneous or intramuscular injection. HHS says it does not intend to take enforcement action against a state-licensed pharmacy, federal facility or licensed physician that compounds it if conditions are met, including a single active ingredient, a patient-specific prescription and an FDA-registered manufacturer with a certificate of analysis [5][6]. The notice says the policy establishes no rights for any person, is not binding and does not put TB-500 on any list [5].
Human data and sport
FDA found no article in which TB-500 was given to a human, and there is no approved dose [1]. WADA names "Thymosin-beta4 and its derivatives e.g. TB-500" in section S2.3 and prohibits it at all times; it appears on the 2026 and 2027 Lists [8][10].
Frequently asked questions
Is TB-500 legal in Illinois?
Does the October 2026 federal policy make TB-500 legal?
Can a pharmacy in Illinois compound TB-500?
Is TB-500 banned in sport?
References
Show all 10 referencesHide references
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- Bulk Drug Substances Used in Compounding of the FD&C Act | FDA.
- Official web page.
- Official web page.
- U.S. Food and Drug Administration.
- World Anti-Doping Agency.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
- World Anti-Doping Agency.